Use of PD-1 (PDCD1) inhibitors for the treatment of Richter syndrome: experience at a single academic centre

Kerry A. Rogers, Ying Huang, Emily Dotson, Jordan Lundberg, Leslie A. Andritsos, Farrukh T. Awan, Jennifer A. Woyach, John C. Byrd

Research output: Contribution to journalLetter

4 Scopus citations
Original languageEnglish (US)
Pages (from-to)363-366
Number of pages4
JournalBritish Journal of Haematology
Volume185
Issue number2
DOIs
StatePublished - Apr 2019

Keywords

  • PD-1 (PDCD1) inhibitors
  • Richter syndrome
  • chronic lymphocytic leukaemia
  • immune checkpoint inhibitors

ASJC Scopus subject areas

  • Hematology

Cite this

Rogers, K. A., Huang, Y., Dotson, E., Lundberg, J., Andritsos, L. A., Awan, F. T., Woyach, J. A., & Byrd, J. C. (2019). Use of PD-1 (PDCD1) inhibitors for the treatment of Richter syndrome: experience at a single academic centre. British Journal of Haematology, 185(2), 363-366. https://doi.org/10.1111/bjh.15508